4 Important Last-Minute Money Moves for 2014
How You Can Easily Replace a Damaged Phone
6 Money Lessons Your Kids Want You to Know
Theme Parks Cash In On the Holidays
View this photo on glassdoor.com
While Gilead's Profits Soar, Uncertainty Reigns Supreme At AbbVie
United Therapeutics Lung Drug Keeps Going And Going
Abbvie's Hep C Regimen Approved, Marketing Battle With Gilead Up Next
Cramer: ‘Downside’ to Biotech as ImmunoGen Stock Cut in Half
The 2015 Calendar Of NASH Trial Catalysts IV: GENFIT And Gilead
3 Pharma Giants Growing Significantly Faster Than Pfizer, Inc.
Jim Cramer's 'Mad Money' Recap: 10 Reasons We'll Have a Santa Claus Rally
Alexion's Rare Disease Model Analyzed
Biogen Idec Poised To Continue Its Stellar Run
Is it Time to Sell Gilead Sciences?